Infection with Hepatitis B Virus May Increase the Serum Concentrations of Osteopontin

Overview

Journal Intervirology

Specialty Microbiology

Date 2021 Mar 18

PMID 33735879

Citations 3

Authors

Hua-Bing Liu

Qin-Yan Chen

Xue-Yan Wang

Lu-Juan Zhang

Li-Ping Hu

Tim J Harrison

Chao Wang

Zhong-Liao Fang

Affiliations

Soon will be listed here.

Abstract

Background: Serum osteopontin (OPN) concentrations were found to be significantly increased in patients infected with hepatitis B virus (HBV) and patients with hepatocellular carcinoma (HCC).

Objective: The aim of this study was to determine the association among HCC, OPN, and HBV.

Methods: Two hundred and forty-one subjects were recruited and divided into 6 groups: healthy controls, asymptomatic HBsAg carriers, HBsAg (-) patients with other tumors, HBsAg (+) chronic liver disease patients, HBsAg (+) patients with HCC, and HBsAg (-) patients with HCC or liver cirrhosis (LC). Serum concentrations of OPN and HBsAg were measured and analyzed.

Results: OPN concentrations in the HBsAg (+) HCC group were significantly higher than the healthy control group and the HBsAg (-) patients with other cancers (both p = 0.0001). The OPN concentrations of the HBsAg (-) patients with HCC or LC also did not differ significantly from those of the healthy control group (p = 0.075). There is a correlation between the titer of HBsAg and concentrations of OPN in all 3 HBsAg (+) groups (all p values <0.05).

Conclusions: Infection with HBV may increase the serum concentrations of OPN. The association of OPN and HCC may be not attributable to tumor development per se but, rather, to HBV infection.

Citing Articles

Current status and new directions for hepatocellular carcinoma diagnosis.

Tu J, Wang B, Wang X, Huo K, Hu W, Zhang R Liver Res. 2025; 8(4):218-236.

PMID: 39958920 PMC: 11771281. DOI: 10.1016/j.livres.2024.12.001.

Increased liver stiffness promotes hepatitis B progression by impairing innate immunity in CCl4-induced fibrotic HBV transgenic mice.

Bybee G, Moeun Y, Wang W, Kharbanda K, Poluektova L, Kidambi S Front Immunol. 2023; 14:1166171.

PMID: 37600826 PMC: 10435739. DOI: 10.3389/fimmu.2023.1166171.

Total Osteopontin and Its Isoform OPN4 Are Differently Expressed in Respiratory Samples during Influenza A(H1N1)pdm09 Infection and Progression.

Martins J, Sousa T, Oliveira M, Gimba E, Siqueira M, da Rocha Matos A Microorganisms. 2023; 11(5).

PMID: 37317323 PMC: 10224194. DOI: 10.3390/microorganisms11051349.

Baseline Plasma Osteopontin Protein Elevation Predicts Adverse Outcomes in Hospitalized COVID-19 Patients.

Tonello S, DOnghia D, Apostolo D, Matino E, Costanzo M, Casciaro G Viruses. 2023; 15(3).

PMID: 36992339 PMC: 10054745. DOI: 10.3390/v15030630.

References

Lund S, Giachelli C, Scatena M . The role of osteopontin in inflammatory processes. J Cell Commun Signal. 2009; 3(3-4):311-22. PMC: 2778587. DOI: 10.1007/s12079-009-0068-0. View

Li J, Chen X, Dai M, Huang S, Chen J, Dai S . Diagnostic accuracy of osteopontin plus alpha-fetoprotein in the hepatocellular carcinoma: A meta-analysis. Clin Res Hepatol Gastroenterol. 2017; 41(5):543-553. DOI: 10.1016/j.clinre.2017.01.010. View

Tang L, Covert E, Wilson E, Kottilil S . Chronic Hepatitis B Infection: A Review. JAMA. 2018; 319(17):1802-1813. DOI: 10.1001/jama.2018.3795. View

Bassyouni I, Bassyouni R, Ibrahim N, Soliman A . Elevated serum osteopontin levels in chronic hepatitis C virus infection: association with autoimmune rheumatologic manifestations. J Clin Immunol. 2012; 32(6):1262-9. DOI: 10.1007/s10875-012-9727-7. View

Rittling S, Singh R . Osteopontin in Immune-mediated Diseases. J Dent Res. 2015; 94(12):1638-45. PMC: 4681477. DOI: 10.1177/0022034515605270. View

Bartkute K, Balsyte D, Wisser J, Kurmanavicius J . Pregnancy outcomes regarding maternal serum AFP value in second trimester screening. J Perinat Med. 2016; 45(7):817-820. DOI: 10.1515/jpm-2016-0101. View

Icer M, Gezmen-Karadag M . The multiple functions and mechanisms of osteopontin. Clin Biochem. 2018; 59:17-24. DOI: 10.1016/j.clinbiochem.2018.07.003. View

Fet V, Dickinson M, Hogan B . Localization of the mouse gene for secreted phosphoprotein 1 (Spp-1) (2ar, osteopontin, bone sialoprotein 1, 44-kDa bone phosphoprotein, tumor-secreted phosphoprotein) to chromosome 5, closely linked to Ric (Rickettsia resistance). Genomics. 1989; 5(2):375-7. DOI: 10.1016/0888-7543(89)90074-8. View

Lamort A, Giopanou I, Psallidas I, Stathopoulos G . Osteopontin as a Link between Inflammation and Cancer: The Thorax in the Spotlight. Cells. 2019; 8(8). PMC: 6721491. DOI: 10.3390/cells8080815. View

10.

Daniele B, Bencivenga A, Salomone Megna A, Tinessa V . Alpha-fetoprotein and ultrasonography screening for hepatocellular carcinoma. Gastroenterology. 2004; 127(5 Suppl 1):S108-12. DOI: 10.1053/j.gastro.2004.09.023. View

11.

Iqbal J, Sarkar-Dutta M, McRae S, Ramachandran A, Kumar B, Waris G . Osteopontin Regulates Hepatitis C Virus (HCV) Replication and Assembly by Interacting with HCV Proteins and Lipid Droplets and by Binding to Receptors αVβ3 and CD44. J Virol. 2018; 92(13). PMC: 6002707. DOI: 10.1128/JVI.02116-17. View

12.

Senger D, Wirth D, Hynes R . Transformed mammalian cells secrete specific proteins and phosphoproteins. Cell. 1979; 16(4):885-93. DOI: 10.1016/0092-8674(79)90103-x. View

13.

Peterson M, Ma C, Spear B . Zhx2 and Zbtb20: novel regulators of postnatal alpha-fetoprotein repression and their potential role in gene reactivation during liver cancer. Semin Cancer Biol. 2011; 21(1):21-7. PMC: 3313486. DOI: 10.1016/j.semcancer.2011.01.001. View

14.

Simao A, Madaleno J, Silva N, Rodrigues F, Caseiro P, Costa J . Plasma osteopontin is a biomarker for the severity of alcoholic liver cirrhosis, not for hepatocellular carcinoma screening. BMC Gastroenterol. 2015; 15:73. PMC: 4487194. DOI: 10.1186/s12876-015-0307-1. View

15.

Nau G, Guilfoile P, Chupp G, Berman J, Kim S, Kornfeld H . A chemoattractant cytokine associated with granulomas in tuberculosis and silicosis. Proc Natl Acad Sci U S A. 1997; 94(12):6414-9. PMC: 21064. DOI: 10.1073/pnas.94.12.6414. View

16.

Pascapurnama D, Labayo H, Dapat I, Nagarajegowda D, Zhao J, Zhang J . Induction of Osteopontin by Dengue Virus-3 Infection in THP-1 Cells: Inhibition of the Synthesis by Brefelamide and Its Derivative. Front Microbiol. 2017; 8:521. PMC: 5370276. DOI: 10.3389/fmicb.2017.00521. View

17.

Khalil A, Elgedawy J, Faramawi M, Elfert A, Salama I, Abbass A . Plasma osteopontin level as a diagnostic marker of hepatocellular carcinoma in patients with radiological evidence of focal hepatic lesions. Tumori. 2013; 99(1):100-7. DOI: 10.1177/030089161309900117. View

18.

Buckwold V, Xu Z, Chen M, Yen T, Ou J . Effects of a naturally occurring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication. J Virol. 1996; 70(9):5845-51. PMC: 190601. DOI: 10.1128/JVI.70.9.5845-5851.1996. View

19.

. Guideline on prevention and treatment of chronic hepatitis B in China (2005). Chin Med J (Engl). 2008; 120(24):2159-73. View

20.

Fang Z, Sabin C, Dong B, Ge L, Wei S, Chen Q . HBV A1762T, G1764A mutations are a valuable biomarker for identifying a subset of male HBsAg carriers at extremely high risk of hepatocellular carcinoma: a prospective study. Am J Gastroenterol. 2008; 103(9):2254-62. PMC: 2566798. DOI: 10.1111/j.1572-0241.2008.01974.x. View